josh-hardman.bsky.social
full of microplastics and writing about psychedelics at psychedelicalpha.com ( @psychedelicalpha.bsky.social )
228 posts
1,051 followers
227 following
Prolific Poster
Conversation Starter
comment in response to
post
Here's a high-level look at how psychedelic patent activity in Jan'25 stacked up against Jan'24.
comment in response to
post
He added that the admin. is going to spend $100-200M on an ad campaign "saying how bad drugs are".
"One of the things we're going to do is we're going to do an advertising campaign, they're working on it right now, and that's saying how bad drugs are for you."
comment in response to
post
"If you notice that every country that has the death penalty has no drug problem, they execute drug dealers."
He told governors they could do it on an individual state basis if they want to.
comment in response to
post
The landmark trial, funded via the Defense Appropriations Act, has a number of interesting features inc. the use of D-amphetamine as a control, a combination of the Lykos Therapeutics model as well as Acceptance and Commitment Therapy (ACT), and a Simultaneous Dosing Paradigm, to name just a few.
comment in response to
post
I spoke with Steve Hely about how he + his co-creator became interested in the topic, their inspirations, + why they believe the storyline hits a nerve.
"The figure of RFK Jr. could’ve been a strange creation of our show had we been inventive enough to concoct him", he told me.
comment in response to
post
In a statement, Dr. Bronner's takes issue with much of the reporting and denies certain specific claims.
Statement: info.drbronner.com/dr-bronners-...
Cease & Desist: info.drbronner.com/wp-content/u...
comment in response to
post
Source: www.washingtonpost.com/business/202...
comment in response to
post
Yes, they were hacked and the hackers posted about a crypto token.
comment in response to
post
RFK Jr. cruising at 75% ish.
comment in response to
post
You can also explore this data via our Psychedelic Drug Development Tracker webpage, which just had a facelift.
Thanks to @michaelhaichin.bsky.social and Noah Smith for making it happen.
psychedelicalpha.com/data/psyched...
comment in response to
post
Some are bullish on the new admin. re: psychedelics.
Genevieve Jurvetson, for example, told the crowd at DLD in Munich that her moonshot goal for 2025 is to see Lykos Therapeutics' MDMA-assisted therapy approved by year-end.
comment in response to
post
Impact of Trump 2.0 on psychedelics field remains unclear.
I discuss:
- Sergey Brin's inauguration presence.
- Trump's initial health-related actions (and omissions).
- A freeze to NIH activity that has stoked funding fears among thousands of researchers.